US 11884718
Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination
granted A61KA61K2039/505A61K2039/5252
Quick answer
US patent 11884718 (Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination) held by The Government of the United States, as represented by the Secretary of the Army expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States, as represented by the Secretary of the Army
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/5252, A61K39/12, A61P